IKS Health (Inventurus Knowledge Solutions) has announced the grant of 150,000 employee stock options to eligible employees under its Employee Stock Option Plan 2022 (IKS ESOP Plan), as approved by the Nomination and Remuneration Committee (NRC) on September 1, 2025.
Each option is convertible into one fully paid-up equity share with a face value of Re. 1. The options are granted at an exercise price of ₹1,514.20 per option, which is not less than the market price, i.e., the last traded price on August 29, 2025, on the National Stock Exchange of India Limited.
The stock options granted can be exercised anytime during the continuous active employment from the date of vesting. The IKS ESOP Plan is administered through a trust. The equity shares allotted upon exercise of the stock options will not be subject to a lock-in period.
The scheme also provides guidelines for handling stock options in cases of death, permanent incapacity, resignation, termination, or retirement. Adjustments will be made for corporate actions such as rights issues, bonus issues, stock splits, mergers, or other reorganizations, in accordance with the IKS ESOP Plan.
The company has made the necessary disclosures under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
Diluted earnings per share pursuant to issue of equity shares on exercise of options and subsequent changes or cancellation or exercise of such options are not applicable.
The company has made the necessary disclosures under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!
